Morphine (generic), MS Contin, Kadian
May 5, 2008
QRxPharma Releases Successful Phase 3 Study Results for 'Dual Opioid' Pain Therapy
“Initial Phase 3 efficacy data demonstrated statistically significant analgesic activity at all doses tested and reinforces the potential clinical benefit and commercial value of QRxPharma's lead dual-opioid product”
"Initial Phase 3 efficacy data demonstrated statistically significant analgesic activity at all doses tested and reinforces the potential clinical benefit and commercial value of QRxPharma's lead dual-opioid ... via Rehab Management
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Take-home methadone concerns lawmakers (from Sep '07) | 3 hr | Dogfart | 600 |
| What is Ultram? (from Nov '06) | 13 hr | time is the ... | 237 |
| Novato nurse charged in mother's megadose of mo... | 19 hr | clem | 4 |
| Another Deadly Drug is Sweeping the Streets (from Jun '06) | Jul 20 | sliverone | 419 |
| Helping America Reduce Methadone Deaths | Jul 20 | Melissa | 4 |
| Finding painkillers balance between help, abuse (from Apr '07) | Jul 20 | time is the ... | 137 |
| DEA's Deadly Decision (from Jan '08) | Jul 17 | Dogfart | 12 |
Most Popular
